Posted by ricker on May 20, 2009, at 20:21:48
In reply to Re: Anyone familiar with this weight control med study, posted by desolationrower on May 20, 2009, at 19:31:36
Now I'm confused??
Is this the same drug and is it on the market?>> Obecure is also pursuing the use of Histalean for preventing the massive weight gain plaguing patients taking olanzapine (Zyprexa), a highly effective antipsychotic medication. The weight gain has been mainly attributed to the anti-histaminic effect of olanzapine in patients' brain and may thus be offset by histaminergic activation. The Company is therefore conducting a clinical trial in eight investigation sites across Canada and in Israel to evaluate the potential of HistaleanTM to attenuate the deleterious effect of co-administered Zyprexa. It is notable that Eli Lilly, manufacturer of Zyprexa, is providing research support to Obecure for conducting this trial.
In addition, the U.S. National Institute of Health (NIH) has undertaken and is conducting a study to examine the drugs mechanism of action and effect on energy balance (consumption and expenditure) in overweight women.
Thanks, Rick
poster:ricker
thread:896858
URL: http://www.dr-bob.org/babble/20090515/msgs/896874.html